ALL NEWS TODAY

[ ALL NEWS TODAY ]

Cedars-Sinai Heart Institute And The Watchman Left Atrial Appendage System

Doctors at the Cedars-Sinai Heart Institute were among the first in California to offer an experimental therapy for atrial fibrillation using the WATCHMAN Left Atrial Appendage System. This is a multicenter Phase II clinical trial, and Cedars-Sinai is one of about 60 centers nationwide participating in the study.
Comments: [0] / Post comment:
06 Jan 2009 14:08:01

Hansen Medical to Present at the 27th Annual JP Morgan Healthcare ... - CNNMoney.com

Hansen Medical to Present at the 27th Annual JP Morgan Healthcare ... CNNMoney.com - The safety and effectiveness of the Sensei system for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial ...
06 Jan 2009 13:22:29

Check here if outside US - The Saginaw News - MLive.com

The Saginaw News - MLive.com Check here if outside US The Saginaw News - MLive.com, MI - George E. Weber, 73, found that out when an allergy he had to his dog, Bear, inadvertently led to doctors diagnosing him with atrial fibrillation, ...
05 Jan 2009 00:12:25

'Incidence of cardiac rhythm disorder increases with age' - Times of India

'Incidence of cardiac rhythm disorder increases with age' Times of India, India - PATNA: Noted heart specialist Dr AK Thakur on Sunday emphasised on timely detection of atrial fibrillation and evaluation of the patient for proper ...
04 Jan 2009 06:44:33

More than two glasses of wine a day can cause heart trouble for women - Entertainment and Showbiz!

More than two glasses of wine a day can cause heart trouble for women Entertainment and Showbiz!, India - Studies assessing the effects of regular alcohol consumption on the risk of atrial fibrillation have provided inconsistent results, with several studies ...
31 Dec 2008 20:42:56

Evaluation of a novel atrial retractor for exposure of the mitral ... - The Journal of Thoracic and Cardiovascular Surgery

Evaluation of a novel atrial retractor for exposure of the mitral ... The Journal of Thoracic and Cardiovascular Surgery - Objectives: To describe a novel atrial retractor and compare 2 methods of intraoperative left atrial retraction for minimally invasive mitral valve repair. ...
28 Dec 2008 15:28:45

Smoking Raises Risk Of Atrial Fibrillation - RedOrbit

Canada.com Smoking Raises Risk Of Atrial Fibrillation RedOrbit, TX - The study found that current and former smokers have an increased risk of a condition known as atrial fibrillation, or AF, the most common type of heart ... Smoking ups risk of common heart rhythm problem Smokers prone to heart arrhythmia
19 Dec 2008 19:12:30

ARYx reports positive data from Phase IIb atrial fibrillation study - Trading Markets (press release)

ARYx reports positive data from Phase IIb atrial fibrillation study Trading Markets (press release), CA - The primary efficacy analysis was the percent change in the atrial fibrillation burden from baseline to the whole 12-week treatment period in the mITT1 ...
18 Dec 2008 14:04:21

ARYx Therapeutics, Inc. Announces Successful Outcome of Atrial ... - MarketWatch

Business Wire (press release) ARYx Therapeutics, Inc. Announces Successful Outcome of Atrial ... MarketWatch - Reported as a reduction in the percentage of time spent in atrial fibrillation compared to baseline, these results provide further evidence that ATI-2042 ... ARYx says heart drug shows promise in mid-stage study ARYx Therapeutics reveals Successful Outcome of Atrial ... ARYx Therapeutics' Heart Beat Drug Shows Effective Responses At ...
16 Dec 2008 23:16:47

Treatments of Atrial Fibrillation Unique at Hillcrest - Greater Tulsa Reporter Newspapers

Greater Tulsa Reporter Newspapers Treatments of Atrial Fibrillation Unique at Hillcrest Greater Tulsa Reporter Newspapers, OK - Dr. David Sandler, director of electrophysiology at Hillcrests Advanced Center for Atrial Fibrillation, 1265 S. Utica Ave., and Dr. Craig Cameron, ...
15 Dec 2008 14:16:10

Daiichi Sankyo Offers New Phase II Data on Atrial Fibrillation ... - Therapeutics Daily (press release) (registration)

Daiichi Sankyo Offers New Phase II Data on Atrial Fibrillation ... Therapeutics Daily (press release) (registration), PA - Patients with non-valvular atrial fibrillation receiving either 30 mg or 60 mg once-daily dose of DU- 176b, an investigational oral Factor Xa inhibitor, ...

Keywords:

ALL NEWS TODAY © PoznaiSebya.Com
Designer Padayatra Dmytriy